Atrium Therapeutics

(NASDAQ) RNA

Current Price$12.99

Market Cap$214.79M

Since IPO (2026)-15%

5 YearN/A

1 YearN/A

1 Month-4%

Atrium Therapeutics Financials at a Glance

Market Cap

$214.79M

Revenue (TTM)

$3.83

Net Income (TTM)

$40.65

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.40 (Low)

Dividend

$0.00

Beta (Volatility)

-0.40 (Low)

Price

$12.99

Volume

162,606.485

Open

$12.50

Price

$12.99

Volume

162,606.485

Open

$12.50

Previous Close

$12.99

Daily Range

$12.50 - $13.06

52-Week Range

$11.95 - $16.77

Dividend

$0.00

Beta (Volatility)

-0.40 (Low)

Price

$12.99

Volume

162,606.485

Open

$12.50

Previous Close

$12.99

Daily Range

$12.50 - $13.06

52-Week Range

$11.95 - $16.77

RNA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Atrium Therapeutics

Industry

Biotechnology

Sector

Health Care

CEO

Kathleen Gallagher

Website

www.atriumtherapeutics.com

Headquarters

San Diego, CA 92121, US

RNA Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-4%

Net Income Margin

-4%

Return on Equity

Return on Capital

-32%

Return on Assets

-28%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$214.79M

Shares Outstanding

17.11M

Volume

162.61K

Avg. Volume

940.36K

Financials (TTM)

Gross Profit

$18.62M

Operating Income

$76.81M

EBITDA

$76.49M

Operating Cash Flow

$41.13M

Capital Expenditure

$1.45M

Free Cash Flow

$42.57M

Cash & ST Invst.

$270.00M

Total Debt

$3.67M

Atrium Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$859.00K

N/A

Gross Profit

$859.00K

N/A

Gross Margin

100.00%

N/A

Market Cap

$214.79M

N/A

Market Cap/Employee

$420.32K

N/A

Employees

511

N/A

Net Income

$29.14M

N/A

EBITDA

$47.91M

N/A

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$266.33M

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$3.67M

N/A

Return on Assets

-27.55%

N/A

Return on Invested Capital

-32.47%

N/A

Free Cash Flow

$20.13M

N/A

Operating Cash Flow

$19.25M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7119.26-0.00%

^DJIDJI

^DJIDJI$48777.95-0.01%

^IXICNASDAQ

^IXICNASDAQ$24595.57-0.00%

BTCBitcoin

BTCBitcoin$75142.00-0.01%

AAPLAAPL

AAPLAAPL$269.89-0.00%

AMZNAMZN

AMZNAMZN$263.63+0.02%

GOOGGOOG

GOOGGOOG$347.55+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$94.75+0.12%

SOFISoFi Technologies

SOFISoFi Technologies$15.53-0.15%

NOKNokia

NOKNokia$12.46+0.10%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$61.86+0.02%

POETPoet Technologies

POETPoet Technologies$6.60-0.18%

ONDSOndas

ONDSOndas$9.49-0.09%

Questions About RNA

What is the current price of Atrium Therapeutics?

Atrium Therapeutics is trading at $12.99 per share.

What is the 52-week range for Atrium Therapeutics?

Over the past 52 weeks, Atrium Therapeutics has traded between $11.95 and $16.77.

How much debt does Atrium Therapeutics have?

As of the most recent reporting period, Atrium Therapeutics reported total debt of $3.67M.

How much cash does Atrium Therapeutics have on hand?

Atrium Therapeutics reported N/A in cash and cash equivalents in its most recent financial results.

What is Atrium Therapeutics’s dividend yield?

Atrium Therapeutics does not currently have a dividend yield.

Atrium Therapeutics

Atrium Therapeutics Financials at a Glance

RNA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Atrium Therapeutics

RNA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Atrium Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RNA

What is the current price of Atrium Therapeutics?

What is the 52-week range for Atrium Therapeutics?

How much debt does Atrium Therapeutics have?

How much cash does Atrium Therapeutics have on hand?

What is Atrium Therapeutics’s dividend yield?

Premium Investing Services